02.1 Oil vs powder

MK-4 oil vs MK-4 powder: carrier, overage and the label

Technical document 02.1 · Reviewed 2026-11-20 · Vitamin K2 MK-4 Oil

On this page
  1. The carrier is the difference
  2. One dose, two masses
  3. The dosage form usually decides
  4. The overage is a formulation decision
  5. The label, format by format
  6. What changes when you switch

MK-4 oil and MK-4 powder carry the same menaquinone-4, CAS 863-61-6, but they are not interchangeable. The oil is a 1.0–1.1% solution in a declared carrier; the powder is the isolated substance at 98.0–102.0%. The carrier changes the ingredient list and the allergen review, the concentration changes the mass behind the label, and the two formats need different overages to hold the same claim at the end of shelf life.

In one line

The oil and the powder carry the same menaquinone-4, but the carrier changes the ingredient list, the overage that holds the label claim, and the mass on the label.

The carrier is the difference

In the 1% oil, roughly 99% of the bottle is carrier: a food-grade oil such as soybean oil or a medium-chain triglyceride. That oil is an ingredient, not packaging. It has to be permitted for the use, named in the ingredient list, covered by the allergen and GMO statements, and specified by its own fatty-acid profile. A change of carrier is a change of product, even when the menaquinone-4 figure stays at 1.05%.

The isolated powder has no carrier. It is menaquinone-4 at 98.0–102.0%, with loss on drying ≤0.5% and ≥95% through 40 mesh. A “powder on carrier” is a third product: the menaquinone diluted on a solid carrier for microgram doses, with its own concentration, blend-uniformity test and label. Do not read it as a packing option on the isolated powder.

The carrier also changes the failure mode. The oil's carrier reacts with oxygen, so the oil carries a peroxide-value limit of ≤10.0 meq O₂/kg; the powder's risk is moisture and heat, so it carries a loss-on-drying limit and a cool, dry storage statement.

One dose, two masses

A label dose counts menaquinone-4. Divide it by the concentration to get the material weight, and the two formats separate quickly: the oil needs about a hundred times the mass of the powder for the same claim.

One MK-4 dose converted to 1% oil and to 98% powder
Label doseOil at 1.0–1.1%Powder at 98–102%Practical reading
45 µg4.1–4.5 mg0.098–0.102 mgThe powder weigh is below production control
1 mg90.9–100 mg0.98–1.02 mgBoth work; the oil is a small fill
5 mg455–500 mg4.9–5.1 mgA softgel for the oil, a small capsule for the powder
10 mg0.91–1.0 g9.8–10.2 mgThe oil fill is growing
45 mg4.1–4.5 g44.1–45.9 mgThe oil no longer fits a standard capsule

The formats meet in the region of about 1–10 mg per serving. Below it, the powder weigh is too small to distribute evenly; above it, the oil mass is too large for a conventional dosage unit. Those are the minimum weights, before overage and the rest of the fill.

The dosage form usually decides

A softgel, a drop or an oily premix needs a liquid, so the oil is the natural starting point. A two-piece capsule, a tablet or a dry blend needs a solid, so the powder is. Putting an oil into a hard capsule is possible but weak: the join can leak and the oil can migrate into the shell. Putting a powder into a softgel works only if the fill is an oil suspension anyway, which brings the carrier question back.

Fill size is the second constraint. A 1 g softgel at 1% oil carries about 10 mg of menaquinone-4; a 45 mg claim would need 4.1–4.5 g of oil, which is outside the usual softgel range. At the other end, a 45 µg claim from the powder needs about 0.1 mg of solid, a weigh no production line controls; that is where the powder on carrier or the oil earns its place.

The overage is a formulation decision

The label declares the amount that must be present at the end of the shelf life, so the fill is set slightly above the claim. That margin is the overage. It is not printed on the label; it is the number that carries the claim to expiry.

The oil needs an overage for oxidation and for the blending window. A 20% overage on a 5 mg claim would fill for 6 mg, which is 545–600 mg of oil instead of 455–500 mg, and the softgel grows with it. The powder needs less margin for assay, because its window is tight, but a small weigh leaves little room to adjust; at microgram doses the overage itself becomes hard to weigh. The justified figure comes from stability data on the format, not from a percentage copied from another product.

An overage also has a ceiling: a large margin can push a nutrient past a market tolerance or a maximum level, and it costs carrier and capsule space. Set it with the stability file and the label review together.

The label, format by format

Label consequences of the two formats
Label element1% oil98% powder
Ingredient listThe carrier oil is namedNo carrier for the isolated powder
Amount declaredThe MK-4 mass; the oil mass is not the declarationThe MK-4 mass
Allergen and GMOThe carrier source drives the statementsNo carrier statement for the isolated form
ConcentrationNot a label figure; it sets the fillNot a label figure; it sets the weigh

In the US, the Supplement Facts panel names vitamin K and the form, menaquinone-4, and gives the amount in micrograms; the carrier appears in the ingredient list. In the EU, the ingredient list names the oil and the carrier, and the nutrition declaration gives vitamin K in micrograms and as a percentage of the reference value. “MK-4 oil” is a description, not a permitted ingredient name in every market, so the buyer's reviewer confirms the wording. The label declares the menaquinone-4, never the carrier mass as if it were the active.

What changes when you switch

A switch changes the specification, the fill weight, the capsule or tablet size, the ingredient list, the allergen statement, the overage and the stability file. The molecule is the same; the product is not. Handle it as a change control: a new specification, a fresh label review and, where the market is regulated, another look at the route.

Do not switch at the balance and adjust the number afterwards. A formula built on 1% oil that is reweighed as 98% powder has a fill about a hundredfold lighter, and a label that still reads “oil” describes a product that is no longer in the bottle. The specifications sit on two product pages, the oil and the powder; the grade page places them in the range; the COA page covers the oil's release tests; the stability page covers the pack; the methods library and the quality page cover the analysis and release.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation